Purification of recombinant bovine normal prion protein PrP(104-242) by HPHIC.

Purification of the prion protein (PrP) is a major concern for biological or biophysical analysis as are the structural specificities of this protein in relation to infectivity. A simple and efficient method for purification of recombinant bovine normal prion protein containing residues 104-242, PrP(104-242) expressed in Escherichia coli by high performance hydrophobic interaction chromatography (HPHIC) was presented in this work. The solution containing denatured and reduced protein in 8.0 mol/L urea extracted from the inclusion body was directly injected into the HPHIC column, aggregates were prevented by the interaction between the denatured PrP(104-242) molecules and the stationary phase during the chromatographic process, the soluble form of PrP(104-242) in aqueous solution was obtained after desorbed from the column. Several factors, including pH value, types of stationary phase and salt, and gradient mode, influencing the purification results were investigated. Optimal conditions were obtained for the purification of PrP(104-242) by HPHIC. This procedure yield PrP(104-242) of a purity of 96% with a recovery of 87%, respectively, for a single step purification of 40 min.

[1]  J. Grosclaude,et al.  High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility. , 2000, European journal of biochemistry.

[2]  F. Cohen,et al.  High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.

[3]  H. Y. Chen,et al.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. , 1992, The New England journal of medicine.

[4]  C. Horváth,et al.  Salt effect on hydrophobic interactions in precipitation and chromatography of proteins: an interpretation of the lyotropic series. , 1977, Archives of biochemistry and biophysics.

[5]  Y. Kato,et al.  Operational variables in high-performance hydrophobic interaction chromatography of proteins on tskgel phenyl-5PW , 1984 .

[6]  C. Horváth,et al.  Liquid Chromatography with Hydrocarbonaceous Bonded Phases; Theory and Practice of Reversed Phase Chromatography , 1977 .

[7]  D. Gajdusek.  Unconventional viruses and the origin and disappearance of kuru. , 1977, Science.

[8]  P. Jadhav,et al.  Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. , 1997, Journal of medicinal chemistry.

[9]  S. Prusiner.  Biology and genetics of prion diseases. , 1994, Annual review of microbiology.

[10]  K Wüthrich,et al.  Human prion proteins expressed in Escherichia coli and purified by high‐affinity column refolding , 1997, FEBS letters.

[11]  Xindu Geng,et al.  High-performance hydrophobic interaction chromatography as a tool for protein refolding , 1992 .

[12]  C. Masters,et al.  The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. , 1981, Brain : a journal of neurology.

[13]  S. Skaper,et al.  The complete mature bovine prion protein highly expressed in Escherichia coli: biochemical and structural studies , 1997, FEBS letters.

[14]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.